ArticleCancers2018

Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial.

Nikolai Siebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.